Once again, continuous glucose monitors (CGMs) and automated insulin delivery systems took most of the headlines, as the leaders in the space keep building on their platforms while challengers continue to enter the fray.

Meanwhile, the industry saw some significant personnel changes, strategy shifts and one major planned separation.